The authors engineered human MSCs transduced with TRAIL and the IRES-eGFP reporter gene, under the control of a tetracycline promoter using a lentiviral vector, and tested their anti-tumor effect on a lung cancer model. The gene discussed is TNFSF10; the disease is lung cancer.